Proteomics-based analysis of a pair of glioma cell lines with different tumor forming characteristics

Neuroscience Letters

Volumn 401, Issue 1-2, 2006, Pages 59-64

  Zhou, Le ^a,b   Wang, Yan ^a   Zhang, Ying tao ^a   Geng, Yi ping ^a   Si, Lu sheng ^a   Wang, Yi li ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Glioma; Proteomics; Recurrence

Indexed keywords

CATHEPSIN D; PROTEIN; PROTEIN SPOT 25; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; DIAGNOSTIC TEST; DNA REPLICATION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR RECURRENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

BRAIN NEOPLASMS; CATHEPSIN D; CELL LINE, TUMOR; CELL PROLIFERATION; DNA REPLICATION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646517893     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.02.080     Document Type: Article

References (33)

1. Bello L., Giussani C., Carrabba G., Pluderi M., Lucini V., Pannacci M., Caronzolo D., Tomei G., Villani R., Scaglione F., Carroll R.S., and Bikfalvi A. Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors. Clin. Cancer Res. 8 (2002) 3539-3548
2. Bigner D.D., Bigner S.H., Ponten J., Westermark B., Mahaley M.S., Ruoslahti E., Herschman H., Eng L.F., and Wikstrand C.J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40 (1981) 201-229
3. Bjorses P., Halonen M., Palvimo J.J., Kolmer M., Aaltonen J., Ellonen P., Perheentupa J., Ulmanen I., and Peltonen L. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 66 (2000) 378-392
4. Cheng C.L., Johnson S.P., Keir S.T., Quinn J.A., Ali O.F., Szabo C., Li H., Salzman A.L., Dolan M.E., Modrich P., Bigner D.D., and Friedman H.S. Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol. Cancer Ther. 4 (2005) 1364-1368
5. Chiron S., Suleau A., and Bonnefoy N. Mitochondrial translation: elongation factor tu is essential in fission yeast and depends on an exchange factor conserved in humans but not in budding yeast. Genetics 169 (2005) 1891-1901
6. Chumbalkar V.C., Subhashini C., Dhople V.M., Sundaram C.S., Jagannadham M.V., Kumar K.N., Srinivas P.N., Mythili R., Rao M.K., Kulkarni M.J., Hegde S., Hegde A.S., Samual C., Santosh V., Singh L., and Sirdeshmukh R. Differential protein expression in human gliomas and molecular insights. Proteomics 5 (2005) 1167-1177
7. Coleman M.T., and Allen N. Activities of enzymes of the hexose monophosphate pathway in nervous system tumors induced by ethylnitrosourea. Acta Neuropathol. (Berl.) 41 (1978) 223-227
8. Du M.X., Sim J., Fang L., Yin Z., Koh S., Stratton J., Pons J., Wang J.J., and Carte B. Identification of novel small-molecule inhibitors for human transketolase by high-throughput screening with fluorescent intensity (FLINT) assay. J. Biomol. Screen. 9 (2004) 427-433
9. Evans J.R., Mitchell S.A., Spriggs K.A., Ostrowski J., Bomsztyk K., Ostarek D., and Willis A.E. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22 (2003) 8012-8020
10. Fang J., Akaike T., and Maeda H. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis 9 (2004) 27-35
11. Forrest G.L., and Gonzalez B. Carbonyl reductase. Chem. Biol. Interact. 129 (2000) 21-40
12. Fukuda M.E., Iwadate Y., Machida T., Hiwasa T., Nimura Y., Nagai Y., Takiguchi M., Tanzawa H., Yamaura A., and Seki N. Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Cancer Res. 65 (2005) 5190-5194
13. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., and Parks W.P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51 (1973) 1417-1423
14. Grube K., and Burkle A. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 11759-11763
15. Harada T., Harada C., Mitamura Y., Akazawa C., Ohtsuka K., and Ohno S. Neurotrophic factor receptors in epiretinal membranes after human diabetic retinopathy. Diabetes Care 25 (2002) 1060-1065
16. Humphrey G.W., Wang Y., Russanova V.R., Hirai T., Qin J., Nakatani Y., and Howard B.H. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 276 (2001) 6817-6824
17. Ishii N., Maier D., Merlo A., Tada M., Sawamura Y., Diserens A.C., and Van E.G.M. Frequent co-alterations of TP53, p16/CDKN2A, p14, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9 (1999) 469-479
18. Jin Z.G., and Berk B.C. SOXF: redox mediators of vascular smooth muscle cell growth. Heart 90 (2004) 488-490
19. Joshi B., Ko D., Ercan D.O., and Chellappan S.P. A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis. Biochem. Biophys. Res. Commun. 312 (2003) 459-466
20. Kim S.H., Lessner S.M., Sakurai Y., Galis Z.S., and Cyclophilin. A as a novel biphasic mediator of endothelial activation and dysfunction. Am. J. Pathol. 164 (2004) 1567-1574
21. Laurent M.V., Maruani H.S., Prebois C., Beaujouin M., Glondu M., Noel A., Alvarez G.M.L., Blacher S., Coopman P., Baghdiguian S., Gilles C., Loncarek J., Freiss G., Vignon F., and Liaudet C.E. Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J. Cell Biol. 168 (2005) 489-499
22. Machado C.M., Schenka A., Vassallo J., Tamashiro W.M., Goncalves E.M., Genari S.C., and Verinaud L. Morphological characterization of a human glioma cell line. Cancer Cell Int. 5 (2005) 13
23. Meli E., Pangallo M., Baronti R., Chiarugi A., Cozzi A., Pellegrini G.D.E., and Moroni F. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage. Toxicol. Lett. 139 (2003) 153-162
24. Nashimoto T., Komata T., Kanzawa T., Aoki H., Endo S., Kon T., Uzuka T., Takahashi H., Kondo S., and Tanaka R. Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells. Int. J. Hyperthermia 21 (2005) 615-629
25. Rao R.D., and James C.D. Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin. Oncol. 31 (2004) 595-604
26. Shinbo Y., Taira T., Niki T., Iguchi A.S.M., and Ariga H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int. J. Oncol. 26 (2005) 641-648
27. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
28. Sivaparvathi M., Sawaya R., Chintala S.K., Go Y., Gokaslan Z.L., and Rao J.S. Expression of cathepsin D during the progression of human gliomas. Neurosci. Lett. 208 (1996) 171-174
29. Snowden A.W., Zhang L., Urnov F., Dent C., Jouvenot Y., Zhong X., Rebar E.J., Jamieson A.C., Zhang H.S., Tan S., Case C.C., Pabo C.O., Wolffe A.P., and Gregory P.D. Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors. Cancer Res. 63 (2003) 8968-8976
30. Vogel T.W., Zhuang Z., Li J., Okamoto H., Furuta M., Lee Y.S., Zeng W., Oldfield E.H., Vortmeyer A.O., and Weil R.J. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme. Clin. Cancer Res. 11 (2005) 3624-3632
31. Yan Z., Fedorov S.A., Mumby M.C., and Williams R.S. PR48, a novel regulatory subunit of protein phosphatase 2A, interacts with Cdc6 and modulates DNA replication in human cells. Mol. Cell Biol. 20 (2000) 1021-1029
32. Yang H., Li M., Chai H., Yan S., Lin P., Lumsden A.B., Yao Q., and Chen C. Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells. J. Surg. Res. 123 (2005) 312-319
33. Zhu Y., and Parada L.F. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer 2 (2002) 616-626